VCT.L Stock Analysis
VC
Neutral
Based on Eyestock quantitative analysis, VCT.L`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Overvalued
Victrex Plc is a holding company, which engages in the manufacture and marketing of polymers. The company is headquartered in Thornton Cleveleys, Lancashire and currently employs 1,093 full-time employees. The firm develops polyetheretherketone (PEEK) and PAEK polymer solutions, and semi-finished and finished parts. The firm also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities. The firm operates through two segments: Industrial and Medical. The Industrial segment is focused on the Company’s energy and industrial, value-added resellers (VAR), automotive, aerospace and electronics markets. The Medical segment is focused on providing specialist solutions for medical device manufacturers. The Company’s subsidiaries include Victrex Manufacturing Limited, Invibio Limited, Invibio Knees Limited, Invibio Device Component, Manufacturing Limited and Juvora Limited.